{{Rsnum
|rsid=20415
|Gene=PTGS2
|Chromosome=1
|position=186681556
|Orientation=minus
|GMAF=0.02893
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PTGS2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.9 | 99.1
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 1.4 | 19.9 | 78.8
| ASW | 0.0 | 14.0 | 86.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 1.9 | 28.0 | 70.1
| MEX | 0.0 | 1.7 | 98.3
| MKK | 1.3 | 17.3 | 81.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|18974063}} [[rs20415]] and [[rs5270]] [[prostate cancer]]

{{ neighbor
| rsid = 20417
| distance = 366
}}
{{ neighbor
| rsid = 689465
| distance = 159
}}

{{PMID|18085997}} Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevance.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}